Monthly Archives: March 2019

//March

WEEKLY SCAN | March 10, 2019

A broad collection of guidance from FDA, EMA, MHRA, Health Canada and TGA.  This week saw a smaller than usual collection of non-guidance documents. Warning letters posted this week include ones demonstrating FDA’s continued focus on OTC product manufacturers,  and manufacturers in India including a particularly testy letter to Pfizer for a Hospira site in India that they are [...]

By |2019-03-19T10:46:55+00:00March 19th, 2019|Weekly Scans|

WEEKLY SCAN | March 3, 2019

The big news this week is the unexpected departure of FDA Commissioner Gottlieb.  No reason is public yet, but he leaves in approximately one month.   FDA Law Blog provides a blog with a nice synopsis of his accomplishments in the two years that he served as FDA Commissioner. We have a couple of interesting guidance from FDA this week [...]

By |2019-03-12T20:09:32+00:00March 12th, 2019|Weekly Scans|

MONTHLY SCAN | February, 2019

Happy Reading, Barbara FDA: TOBACCO: The FR announced availability of a revised draft guidance ‘Use of Investigational Tobacco Products.’ TOBACCO: The FR published a draft guidance, ‘Smoking Cessation and Related Indications:  Developing Nicotine Replacement Therapy Drug Products.’ TOBACCO: The FR announced availability of the draft guidance, ‘Enforcement policy for Certain Marketed Tobacco Products’ BLOOD ESTABLISHMENTS: Exceptions and Alternative [...]

By |2019-03-07T14:09:55+00:00March 6th, 2019|Monthly Scans|

WEEKLY SCAN | February 24, 2019

Another busy week with guidance publication from both the US and Europe.  Good for reading on a rainy or cold weekend.  We have the usual collection of non-guidance documents from the EMA, FDA, MHR and HPRA.  This includes two annual reports from the FDA. Enforcement saw a few warning letters, and two forms 483 from recent inspections. The two [...]

By |2019-03-05T19:40:25+00:00March 4th, 2019|Weekly Scans|